Theratechnologies Company Insiders
| THTX Stock | USD 1.20 0.01 0.83% |
Theratechnologies employs about 103 people. The company is managed by 8 executives with a total tenure of roughly 241 years, averaging almost 30.0 years of service per executive, having 12.88 employees per reported executive. Break down of Theratechnologies' management performance can provide insight into the company performance.
Theratechnologies |
Theratechnologies Management Team Effectiveness
The company has return on total asset (ROA) of 0.1176 % which means that it generated a profit of $0.1176 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (11.1686) %, meaning that it created substantial loss on money invested by shareholders. Theratechnologies' management efficiency ratios could be used to measure how well Theratechnologies manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to rise to 1.39 in 2024, whereas Return On Tangible Assets are likely to drop (0.44) in 2024. At this time, Theratechnologies' Non Current Assets Total are fairly stable compared to the past year. Other Assets is likely to rise to about 2.2 M in 2024, whereas Total Assets are likely to drop slightly above 65.2 M in 2024.Common Stock Shares Outstanding is likely to drop to about 23.5 M in 2024. Net Loss is likely to rise to about (40.4 M) in 2024
Theratechnologies Workforce Comparison
Theratechnologies is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 1,861. Theratechnologies holds roughly 103 in number of employees claiming about 6% of equities under Health Care industry.
Theratechnologies Profit Margins
The company has Profit Margin (PM) of (0.04) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.27 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.27.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.96 | 0.87 |
|
|
Theratechnologies Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Theratechnologies Price Series Summation is a cross summation of Theratechnologies price series and its benchmark/peer.
Theratechnologies Notable Stakeholders
A Theratechnologies stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Theratechnologies often face trade-offs trying to please all of them. Theratechnologies' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Theratechnologies' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Paul Lvesque | CEO President | Profile | |
| MBA MBA | Senior CFO | Profile | |
| LLB BA | VP Affairs | Profile | |
| H MSc | Vice Resources | Profile | |
| LLB LLM | General Secretary | Profile | |
| Elif McDonald | Director Relations | Profile | |
| Christian Marsolais | Senior Officer | Profile | |
| John Leasure | Global Officer | Profile |
About Theratechnologies Management Performance
The success or failure of an entity such as Theratechnologies often depends on how effective the management is. Theratechnologies management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Theratechnologies management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Theratechnologies management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.42) | (0.44) | |
| Return On Capital Employed | (0.31) | (0.33) | |
| Return On Assets | (0.35) | (0.37) | |
| Return On Equity | 1.32 | 1.39 |
Please note, the imprecision that can be found in Theratechnologies' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Theratechnologies. Check Theratechnologies' Beneish M Score to see the likelihood of Theratechnologies' management manipulating its earnings.
Theratechnologies Workforce Analysis
Traditionally, organizations such as Theratechnologies use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Theratechnologies within its industry.Theratechnologies Manpower Efficiency
Return on Theratechnologies Manpower
| Revenue Per Employee | 793.8K | |
| Revenue Per Executive | 10.2M | |
| Net Loss Per Employee | 232.6K | |
| Net Loss Per Executive | 3M | |
| Working Capital Per Employee | 155.4K | |
| Working Capital Per Executive | 2M |
Additional Tools for Theratechnologies Stock Analysis
When running Theratechnologies' price analysis, check to measure Theratechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theratechnologies is operating at the current time. Most of Theratechnologies' value examination focuses on studying past and present price action to predict the probability of Theratechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theratechnologies' price. Additionally, you may evaluate how the addition of Theratechnologies to your portfolios can decrease your overall portfolio volatility.